Treatment delay in Melanoma: A risk factor analysis of an impending crisis

Marcus L. Elias; Ann M. John; Spandana Maddukuri; Robert A. Schwartz; W. Clark Lambert

doi:10.12788/cutis.0235

Treatment delay in Melanoma: A risk factor analysis of an impending crisis

Marcus L. Elias, Ann M. John, Spandana Maddukuri, Robert A. Schwartz, W. Clark Lambert

New Jersey Medical School (NJMS), Medicine, Division of Dermatology

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Risk factors associated with melanoma treatment delay (MTD) have been inadequately studied. To elucidate MTD associations based on patient and tumor characteristics, a retrospective cohort study was performed for cutaneous melanoma cases reported to the National Cancer Database (NCDB) between 2004 and 2015. We evaluated the number of days from diagnosis to treatment initiation, analyzing postponements more than 45 days as moderate MTD (mMTD) and postponements more than 90 days as severe MTD (sMTD). Greater MTD rates were independently associated with patients who are older than 50 years, female, nonwhite, not privately insured, and treated at an academic facility and who have more advanced tumor stage and head/neck primaries.

Original language	English (US)
Pages (from-to)	E19-E26
Journal	Cutis
Volume	107
Issue number	4
DOIs	https://doi.org/10.12788/cutis.0235
State	Published - Apr 2021

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

10.12788/cutis.0235

Cite this

@article{49130036b1a045c791d5addecf922c24,

title = "Treatment delay in Melanoma: A risk factor analysis of an impending crisis",

abstract = "Risk factors associated with melanoma treatment delay (MTD) have been inadequately studied. To elucidate MTD associations based on patient and tumor characteristics, a retrospective cohort study was performed for cutaneous melanoma cases reported to the National Cancer Database (NCDB) between 2004 and 2015. We evaluated the number of days from diagnosis to treatment initiation, analyzing postponements more than 45 days as moderate MTD (mMTD) and postponements more than 90 days as severe MTD (sMTD). Greater MTD rates were independently associated with patients who are older than 50 years, female, nonwhite, not privately insured, and treated at an academic facility and who have more advanced tumor stage and head/neck primaries.",

author = "Elias, {Marcus L.} and John, {Ann M.} and Spandana Maddukuri and Schwartz, {Robert A.} and Lambert, {W. Clark}",

note = "Publisher Copyright: Copyright {\textcopyright} Cutis 2021. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher.",

year = "2021",

month = apr,

doi = "10.12788/cutis.0235",

language = "English (US)",

volume = "107",

pages = "E19--E26",

journal = "Cutis",

issn = "0011-4162",

publisher = "Frontline Medical Communications Inc.",

number = "4",

}

TY - JOUR

T1 - Treatment delay in Melanoma

T2 - A risk factor analysis of an impending crisis

AU - Elias, Marcus L.

AU - John, Ann M.

AU - Maddukuri, Spandana

AU - Schwartz, Robert A.

AU - Lambert, W. Clark

PY - 2021/4

Y1 - 2021/4

N2 - Risk factors associated with melanoma treatment delay (MTD) have been inadequately studied. To elucidate MTD associations based on patient and tumor characteristics, a retrospective cohort study was performed for cutaneous melanoma cases reported to the National Cancer Database (NCDB) between 2004 and 2015. We evaluated the number of days from diagnosis to treatment initiation, analyzing postponements more than 45 days as moderate MTD (mMTD) and postponements more than 90 days as severe MTD (sMTD). Greater MTD rates were independently associated with patients who are older than 50 years, female, nonwhite, not privately insured, and treated at an academic facility and who have more advanced tumor stage and head/neck primaries.

AB - Risk factors associated with melanoma treatment delay (MTD) have been inadequately studied. To elucidate MTD associations based on patient and tumor characteristics, a retrospective cohort study was performed for cutaneous melanoma cases reported to the National Cancer Database (NCDB) between 2004 and 2015. We evaluated the number of days from diagnosis to treatment initiation, analyzing postponements more than 45 days as moderate MTD (mMTD) and postponements more than 90 days as severe MTD (sMTD). Greater MTD rates were independently associated with patients who are older than 50 years, female, nonwhite, not privately insured, and treated at an academic facility and who have more advanced tumor stage and head/neck primaries.

UR - http://www.scopus.com/inward/record.url?scp=85107293427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85107293427&partnerID=8YFLogxK

U2 - 10.12788/cutis.0235

DO - 10.12788/cutis.0235

M3 - Article

C2 - 34096856

AN - SCOPUS:85107293427

SN - 0011-4162

VL - 107

SP - E19-E26

JO - Cutis

JF - Cutis

IS - 4

ER -

Treatment delay in Melanoma: A risk factor analysis of an impending crisis

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this